Stock METROPOLIS METROPOLIS HEALTHCARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Metropolis Healthcare Limited

Equities

METROPOLIS

INE112L01020

Healthcare Facilities & Services

End-of-day quote NSE India S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
1,805 INR +1.89% Intraday chart for Metropolis Healthcare Limited +3.76% +7.56%
Apr. 11 Metropolis Healthcare Books 10% Increase in Fiscal Q4 Overall Revenue MT
Apr. 10 Metropolis Healthcare Limited Announces Consolidated Revenue Results for the Fourth Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 65,032 114,563 104,174 63,926 92,471 - -
Enterprise Value (EV) 1 62,802 110,283 104,952 63,654 91,182 89,847 88,244
P/E ratio 50.9 x 62.6 x 48.9 x 44.9 x 67.8 x 50.4 x 40.9 x
Yield 0.62% 0.36% 0.39% 0.64% 0.53% 0.7% 0.86%
Capitalization / Revenue 7.59 x 11.5 x 8.48 x 5.57 x 7.78 x 6.81 x 6.06 x
EV / Revenue 7.33 x 11.1 x 8.54 x 5.54 x 7.67 x 6.62 x 5.78 x
EV / EBITDA 27 x 38.6 x 30.6 x 22.1 x 32.1 x 26 x 21.9 x
EV / FCF 33.8 x 49.9 x 47.1 x 32.7 x 52.5 x 37.4 x 29.8 x
FCF Yield 2.96% 2% 2.12% 3.05% 1.9% 2.67% 3.35%
Price to Book 12.4 x 16.2 x 11.8 x 6.47 x 8.62 x 7.78 x 6.97 x
Nbr of stocks (in thousands) 50,631 51,117 51,172 51,211 51,229 - -
Reference price 2 1,284 2,241 2,036 1,248 1,805 1,805 1,805
Announcement Date 5/29/20 5/27/21 5/24/22 5/16/23 - - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 7,694 8,564 9,980 12,283 11,482 11,893 13,579 15,262
EBITDA 1 2,086 2,328 2,860 3,428 2,883 2,840 3,460 4,025
EBIT 1 - 1,685 2,401 2,796 1,991 1,942 2,457 2,974
Operating Margin - 19.68% 24.05% 22.76% 17.34% 16.33% 18.09% 19.49%
Earnings before Tax (EBT) 1 - 1,687 2,443 2,934 1,875 1,817 2,449 3,034
Net income 1 - 1,273 1,831 2,142 1,429 1,347 1,830 2,267
Net margin - 14.87% 18.35% 17.44% 12.44% 11.32% 13.47% 14.86%
EPS 2 24.02 25.25 35.79 41.66 27.81 26.62 35.84 44.11
Free Cash Flow 1 - 1,858 2,208 2,226 1,945 1,735 2,400 2,960
FCF margin - 21.7% 22.13% 18.12% 16.94% 14.59% 17.67% 19.39%
FCF Conversion (EBITDA) - 79.81% 77.22% 64.94% 67.45% 61.1% 69.37% 73.53%
FCF Conversion (Net income) - 145.94% 120.62% 103.94% 136.1% 128.88% 131.17% 130.53%
Dividend per Share 2 13.26 8.000 8.000 8.000 8.000 9.566 12.68 15.50
Announcement Date 5/13/19 5/29/20 5/27/21 5/24/22 5/16/23 - - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 2,748 2,917 3,268 3,026 2,931 3,059 2,799 3,003 2,855 2,825 2,771 3,059 2,932 3,052 3,106
EBITDA 1 866.4 963.9 1,024 902.4 753.3 748.5 684.9 790.3 704.9 702.9 629.4 769.6 709.6 753.6 -
EBIT 1 756.7 823.1 890.6 752 584.4 568.6 473.2 574.5 474.6 468.5 421.2 545.2 489.9 509.2 554.2
Operating Margin 27.54% 28.21% 27.26% 24.85% 19.94% 18.59% 16.91% 19.13% 16.63% 16.58% 15.2% 17.82% 16.71% 16.68% 17.85%
Earnings before Tax (EBT) 1 777.7 816.5 1,031 777.1 560.9 564.7 428.3 548 479.7 - 391.9 511.3 451.5 510.2 -
Net income 1 585.7 613.5 748.9 582.7 410.4 399.9 334 403.3 358 333.6 289.8 390.8 336.4 382 -
Net margin 21.32% 21.03% 22.92% 19.25% 14% 13.07% 11.93% 13.43% 12.54% 11.81% 10.46% 12.78% 11.47% 12.51% -
EPS 2 11.46 11.99 14.58 11.34 7.980 7.780 6.490 7.850 6.970 6.490 5.610 7.592 6.872 7.207 8.230
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 2/10/21 5/27/21 8/6/21 11/10/21 2/11/22 5/24/22 8/10/22 11/8/22 2/10/23 5/16/23 8/2/23 - - - -
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - 779 - - - -
Net Cash position 1 - 2,230 4,280 - 272 1,289 2,624 4,226
Leverage (Debt/EBITDA) - - - 0.2271 x - - - -
Free Cash Flow 1 - 1,858 2,208 2,226 1,945 1,735 2,400 2,960
ROE (net income / shareholders' equity) - 31% 29.8% 26.9% 15.2% 12.9% 16.2% 18.1%
ROA (Net income/ Total Assets) - - 20.8% 16.9% 9.43% - - -
Assets 1 - - 8,783 12,674 15,160 - - -
Book Value Per Share 2 - 103.0 138.0 173.0 193.0 209.0 232.0 259.0
Cash Flow per Share 2 18.00 - 48.70 49.30 48.10 45.60 59.70 66.60
Capex 1 196 292 282 307 526 481 500 457
Capex / Sales 2.54% 3.41% 2.82% 2.5% 4.58% 4.04% 3.68% 2.99%
Announcement Date 5/13/19 5/29/20 5/27/21 5/24/22 5/16/23 - - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Metropolis Healthcare Limited

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
1,805 INR
Average target price
1,689 INR
Spread / Average Target
-6.41%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+7.56% 1.11B
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-17.39% 8.25B
RADNET, INC. Stock RadNet, Inc.
+39.20% 3.58B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-39.11% 2.46B
SYNLAB AG Stock SYNLAB AG
-8.06% 2.46B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-7.35% 2.38B
FLEURY S.A. Stock Fleury S.A.
-19.01% 1.55B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-40.66% 1.21B
ADICON HOLDINGS LIMITED Stock Adicon Holdings Limited
-14.72% 1.03B
OPKO HEALTH, INC. Stock OPKO Health, Inc.
-16.56% 878M
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. METROPOLIS Stock
  4. Financials Metropolis Healthcare Limited